Nalls Sherbakoff Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50.9K Hold
42
0.04% 179
2026
Q1
$39.1K Hold
42
0.03% 212
2025
Q4
$45.6K Hold
42
0.03% 211
2025
Q3
$32.4K Sell
42
-101
-71% -$75.2K 0.02% 245
2025
Q2
$111K Buy
143
+1
+0.7% +$777 0.08% 133
2025
Q1
$118K Buy
+142
New +$118K 0.1% 116
2023
Q4
$175K Buy
300
+49
+20% +$28.6K 0.16% 93
2023
Q3
$135K Sell
251
-199
-44% -$103K 0.13% 101
2023
Q2
$193K Buy
450
+44
+11% +$18.5K 0.19% 76
2023
Q1
$138K Buy
+406
New +$137K 0.14% 100
2018
Q4
$17K Buy
+150
New +$16.8K 0.03% 225

Other funds holding LLY

Nalls Sherbakoff Group's LLY Position: Q2 2026 in Review

Nalls Sherbakoff Group held its Eli Lilly (LLY) position steady in Q2 2026 at 42 shares worth $50.9K. The position accounts for 0.04% of the portfolio, ranked #179.

Nalls Sherbakoff Group first reported a position in LLY in Q4 2018 and has held it in 11 quarters since. The position peaked at $193K in Q2 2023. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Nalls Sherbakoff Group held 42 shares of Eli Lilly worth $50.9K as of Q2 2026.
  • Nalls Sherbakoff Group left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.04% of Nalls Sherbakoff Group's portfolio in Q2 2026, its #179 holding.
  • Nalls Sherbakoff Group first reported a position in Eli Lilly in Q4 2018 and has held it in 11 quarters since.
  • Nalls Sherbakoff Group's Eli Lilly position peaked at $193K in Q2 2023.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Nalls Sherbakoff Group's 13F filing for Q2 2026, filed 17 Aug 2026.